Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Orosz ZZ, Bárdos H, Shemirani AH, Beke Debreceni I, Lassila R, Riikonen AS, Kremer Hovinga JA, Seiler TG, van Dorland HA, Schroeder V, Boda Z, Nemes L, Früh Eppstein B, Nagy B, Facskó A, Kappelmayer J, Muszbek L. Orosz ZZ, et al. Among authors: nemes l. Int J Mol Sci. 2019 Nov 27;20(23):5963. doi: 10.3390/ijms20235963. Int J Mol Sci. 2019. PMID: 31783511 Free PMC article.
Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center.
Gindele R, Selmeczi A, Oláh Z, Ilonczai P, Pfliegler G, Marján E, Nemes L, Nagy Á, Losonczy H, Mitic G, Kovac M, Balogh G, Komáromi I, Schlammadinger Á, Rázsó K, Boda Z, Muszbek L, Bereczky Z. Gindele R, et al. Among authors: nemes l. Thromb Res. 2017 Dec;160:119-128. doi: 10.1016/j.thromres.2017.10.023. Epub 2017 Oct 31. Thromb Res. 2017. PMID: 29153735
Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.
Mohl A, Boda Z, Jager R, Losonczy H, Marosi A, Masszi T, Nagy E, Nemes L, Obser T, Oyen F, Radványi G, Schlammadinger Á, Szélessy ZS, Várkonyi A, Vezendy K, Vilimi B, Schneppenheim R, Bodó I. Mohl A, et al. Among authors: nemes l. J Thromb Haemost. 2011 May;9(5):945-52. doi: 10.1111/j.1538-7836.2011.04250.x. J Thromb Haemost. 2011. PMID: 21362127 Free article.
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
Bidlingmaier C, Kurnik K, Escuriola-Ettingshausen C, Jager R, Klamroth R, Male C, Marosi A, Nemes L, von Stackelberg A, Kreuz W. Bidlingmaier C, et al. Among authors: nemes l. Haemophilia. 2011 Sep;17(5):e837-40. doi: 10.1111/j.1365-2516.2011.02577.x. Epub 2011 Jun 7. Haemophilia. 2011. PMID: 21649797 No abstract available.
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
Gruppo RA, Malan D, Kapocsi J, Nemes L, Hay CRM, Boggio L, Chowdary P, Tagariello G, von Drygalski A, Hua F, Scaramozza M, Arkin S; Marzeptacog alfa (activated) Study Group Investigators. Gruppo RA, et al. Among authors: nemes l. J Thromb Haemost. 2018 Oct;16(10):1984-1993. doi: 10.1111/jth.14247. Epub 2018 Aug 27. J Thromb Haemost. 2018. PMID: 30151972 Free article. Clinical Trial.
100 results